Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Generation of induced pluripotent stem cell line derived from FNAIT patient with CD36 deficiency mutations.

Stem cell research - 1 May 2022

Chen Dawei, Wang Tao, Ye Xin, Xu Xiuzhang, Xia Wenjie, Fu Yongshui

Abstract excerpt

Fetal and neonatal alloimmune thrombocytopenia (FNAIT) caused by anti-CD36 isoantibodies is a common disease and the frequency of type I CD36 deficiency is relatively high in eastern Asian populations.Currently, patient-specific induced pluripotent stem cells (hiPSC) are believed to be useful tools for studying anti-CD36 mediated FNAIT and finding new therapeutic approaches to the disease.We generated an iPSC...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Platelet Disorders
Share to Cell Line
Share to Genetic Diseases, Inborn

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Induced Pluripotent Stem Cells

Share to Infant, Newborn

Share to Leukocytes, Mononuclear

Share to Mutation

Source

Identifiers

PMID: 35305469
DOI: 10.1016/j.scr.2022.102749

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Generation of induced pluripotent stem cell line derived from FNAIT patient with CD36 deficiency mutations.PMID 35305469Read ↗

Platelet CD36 deficiency is present in 2.6% of Arabian individuals and can cause NAIT and platelet refractoriness.Semantic proximity Read ↗

Generation of human induced pluripotent stem cell lines (NIHTVBi011-A, NIHTVBi012-A, NIHTVBi013-A) from autosomal dominant Hyper IgE syndrome (AD-HIES) patients carrying STAT3 mutation.Semantic proximity Read ↗

Studies on CD36 deficiency in South China: Two cases demonstrating the clinical impact of anti-CD36 antibodies.Semantic proximity Read ↗

Eight induced pluripotent stem cell lines (iPSCs) derived from two patients with Leukocyte adhesion deficiency Type I (LAD I) with mutations in the ITGB2 gene.Semantic proximity Read ↗

Fetal/neonatal alloimmune thrombocytopenia due to anti‐ CD36 antibodies: antibody evaluations by CD36 ‐transfected cell linesSemantic proximity Read ↗

Generation and characterization of HLA-universal platelets derived from induced pluripotent stem cellsSemantic proximity Read ↗

Human-induced pluripotent stem cell lines (CMCi006-A and CMCi007-A) from a female and male patient with Fabry disease carrying the same frameshift deletion mutation.Semantic proximity Read ↗

Generation of human induced pluripotent stem cell line (AOUMEYi001-A) from a patient affected by Congenital disorders of glycosylation (ALG8-CDG) using self-replicating RNA vector.Semantic proximity Read ↗

Generation of human induced pluripotent stem cell line MHHi029-A from a male Fabry disease patient carrying c.959A > T mutation.Semantic proximity Read ↗

Generation and characterization of a human iPSC line SANi006-A from a Gray Platelet Syndrome patient.Semantic proximity Read ↗

Evidence that CD36 is expressed on red blood cells and constitutes a novel blood group system of clinical importanceSemantic proximity Read ↗

Generation of HLA-Universal iPSC-Derived Megakaryocytes and Platelets for Survival Under Refractoriness ConditionsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.